Previous 10 | Next 10 |
2024-06-10 10:25:57 ET More on Geron Geron: Innovative Rytelo Enters A Challenging MDS Market Geron Corporation: A High-Risk Deal With A Good Chance Of Success Geron jumps as FDA approves lead asset for blood cancer Geron Corporation (GERN) Q1 2024 Earnings C...
2024-06-10 09:30:06 ET Barclays analyst issues OVERWEIGHT recommendation for GERN on June 10, 2024 08:08AM ET. GERN was trading at $4.59 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy, 1 - Hold r...
2024-06-10 08:00:07 ET Stephen Willey from Stifel Nicolaus issued a price target of $7.00 for GERN on 2024-06-10 06:39:00. The adjusted price target was set to $7.00. At the time of the announcement, GERN was trading at $4.59. The overall price target consensus is at $5....
2024-06-08 08:00:00 ET Summary The FDA approved Geron's Rytelo for specific low-risk MDS patients, a significant milestone for the company. Rytelo faces stiff competition in the MDS market, particularly from drugs like Reblozyl, which limits its market share. Geron's financial...
2024-06-08 06:37:00 ET Shares of Geron (NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was reacting to news the company's investors had been waiting to hear for decades. On June 6, the U.S. Food and Drug Administration (FDA) approved Geron's first drug...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 12.2% to $0.6106 on volume of 413,566,315 shares Trinity Place Holdings Inc. (TPHS) rose 44.6% to $0.1756 on volume of 351,549,876 shares Presto Automation Inc. (PRST) rose 17.4% to...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 37.2% to $0.7466 on volume of 94,759,512 shares GameStop Corporation (GME) rose 0.0% to $46.5702 on volume of 64,189,668 shares Trinity Place Holdings Inc. (TPHS) rose 126.9% to $0....
2024-06-07 09:00:40 ET More on related stocks: Roaring Kitty Sparks GameStop Surge With $100M Bet: Analysis And Insights GameStop Stock: Disconnected From Fundamentals GameStop: 'Roaring Kitty' Is Back, Nearly All-In With $175 Million Bet Lyft attracts analys...
2024-06-06 22:31:45 ET More on Geron Geron Corporation: A High-Risk Deal With A Good Chance Of Success Geron Corporation (GERN) Q1 2024 Earnings Call Transcript Geron: FDA PDUFA Review With Continued Imetelstat Advancement Geron GAAP EPS of -$0.09 beats by $0...
Approval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion independence, increases in hemoglobin levels and reduction in transfusion burden o...
News, Short Squeeze, Breakout and More Instantly...
RYTELO, for both RS+ and RS- patients, has a Category 1 recommendation for second-line treatment and a Category 2A recommendation for first-line treatment of patients who are ESA ineligible (serum EPO >500 mU/mL) Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart the Company on August 31, 2024, to ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the market opens on Thursday, August 8, 2024 via press release, which will be available on the Company ...